Shoulder Innovations, Inc. (NYSE:SI) Given Consensus Recommendation of “Moderate Buy” by Analysts

by · The Cerbat Gem

Shares of Shoulder Innovations, Inc. (NYSE:SI – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $20.60.

A number of equities analysts have commented on the company. Wall Street Zen raised Shoulder Innovations from a “sell” rating to a “hold” rating in a research note on Saturday, October 11th. Morgan Stanley upped their price target on shares of Shoulder Innovations from $18.00 to $23.00 and gave the company an “overweight” rating in a report on Tuesday, December 2nd. Piper Sandler reissued an “overweight” rating and set a $18.00 price target on shares of Shoulder Innovations in a research report on Wednesday, November 12th. The Goldman Sachs Group restated a “buy” rating on shares of Shoulder Innovations in a research report on Friday, January 9th. Finally, Weiss Ratings reaffirmed a “sell (e)” rating on shares of Shoulder Innovations in a research note on Monday, December 29th.

Read Our Latest Analysis on SI

Insider Buying and Selling

In other Shoulder Innovations news, CEO Robert Joseph Ball acquired 3,900 shares of the company’s stock in a transaction on Friday, December 12th. The stock was acquired at an average price of $14.89 per share, for a total transaction of $58,071.00. Following the acquisition, the chief executive officer owned 118,457 shares in the company, valued at $1,763,824.73. This represents a 3.40% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Over the last three months, insiders purchased 9,200 shares of company stock worth $136,642. Corporate insiders own 1.71% of the company’s stock.

Hedge Funds Weigh In On Shoulder Innovations

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Shoulder Innovations in the third quarter valued at $28,000. Rhumbline Advisers purchased a new stake in shares of Shoulder Innovations in the 3rd quarter worth about $54,000. Board of Trustees of The Leland Stanford Junior University purchased a new stake in shares of Shoulder Innovations in the 3rd quarter worth about $170,000. Bank of America Corp DE purchased a new position in shares of Shoulder Innovations during the third quarter valued at about $322,000. Finally, Monashee Investment Management LLC purchased a new position in shares of Shoulder Innovations during the third quarter valued at about $502,000.

Shoulder Innovations Stock Up 5.1%

Shoulder Innovations stock opened at $15.13 on Friday. The stock has a fifty day simple moving average of $14.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 11.09 and a quick ratio of 9.80. Shoulder Innovations has a twelve month low of $10.92 and a twelve month high of $17.94. The company has a market capitalization of $311.62 million and a P/E ratio of -0.13.

Shoulder Innovations (NYSE:SI – Get Free Report) last released its quarterly earnings data on Tuesday, November 11th. The company reported ($0.48) EPS for the quarter, missing the consensus estimate of ($0.37) by ($0.11). The firm had revenue of $11.76 million during the quarter, compared to analysts’ expectations of $9.99 million. As a group, equities analysts expect that Shoulder Innovations will post -0.56 earnings per share for the current fiscal year.

About Shoulder Innovations

(Get Free Report)

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.

Read More